Arabic Arabic English English French French German German
dark

G2 Bio Companies Launch with US$200 Million to Develop Transformative Genetic-Based Therapies

– Partnership between University of Pennsylvania Gene Therapy Program, James Wilson, M.D., Ph.D., Tachi Yamada, M.D., and Temasek – US$200 million financing commitment from Temasek to fund development of next-generation gene therapy companies with Penn’s Gene Therapy Program Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

OAG report into vaccine programme ‘useful and timely’ says Ministry

Next Post

Kelyniam Global Releases Q1 Financial Results – Profitability Despite the 2nd Wave Pandemic

Related Posts
Total
0
Share